Sale!

MPI Gene Glycosylation Disorder Type 1B Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “MPI Gene Glycosylation Disorder Type 1B Genetic Test” is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying mutations in the MPI gene. These mutations are responsible for a rare condition known as Congenital Disorders of Glycosylation Type 1b (CDG-1b), which affects the body’s ability to properly glycosylate proteins and lipids, essential processes for normal cellular function. CDG-1b can lead to a wide range of symptoms, including developmental delay, gastrointestinal problems, and liver dysfunction, among others.

Given the complexity of this disorder and its potential impact on various body systems, early and accurate diagnosis is crucial for managing symptoms and improving quality of life. The test involves analyzing the patient’s DNA to look for specific mutations in the MPI gene that are indicative of CDG-1b. This genetic testing is a critical step in confirming the diagnosis, enabling targeted treatment plans, and providing genetic counseling for affected families.

The cost of the MPI Gene Glycosylation Disorder Type 1B Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated nature of the testing process, which requires advanced genetic sequencing technologies and expert analysis to ensure accurate results. Patients and healthcare providers considering this test can expect a high level of diagnostic accuracy, which is essential for the effective management of CDG-1b.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MPI Gene Glycosylation disorder type 1B Genetic Test

Genetic testing plays a crucial role in diagnosing and managing various genetic disorders. One such test is the MPI Gene Glycosylation disorder type 1B Genetic Test offered by DNA Labs UAE.

Test Details

The MPI Gene Glycosylation Disorder Type 1B NGS Genetic Test is a type of genetic test that identifies mutations or variations in the MPI gene. The MPI gene is responsible for producing the enzyme mannose phosphate isomerase, which is involved in the glycosylation process that adds sugar molecules to proteins.

Mutations or variations in the MPI gene can lead to MPI gene glycosylation disorder type 1B, also known as MPI-CDG (Congenital Disorders of Glycosylation). This disorder affects the glycosylation process, resulting in various symptoms such as developmental delays, intellectual disability, growth abnormalities, liver dysfunction, and neurological problems.

The MPI Gene Glycosylation Disorder Type 1B NGS Genetic Test utilizes Next-Generation Sequencing (NGS) technology to analyze the DNA sequence of the MPI gene. This allows for the identification of any mutations or variations that may be present.

Test Components and Price

The MPI Gene Glycosylation disorder type 1B Genetic Test costs AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA Card.

Report Delivery and Method

The test results are typically delivered within 3 to 4 weeks. The NGS technology is employed to analyze the DNA sequence of the MPI gene.

Test Type and Doctor

The MPI Gene Glycosylation disorder type 1B Genetic Test falls under the category of Metabolic Disorders. The test is conducted under the supervision of a General Physician in the Genetics department.

Pre Test Information

Prior to the test, it is essential to provide the clinical history of the patient who is undergoing the MPI Gene Glycosylation disorder type 1B NGS Genetic DNA Test. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected by Glycosylation disorder type 1B.

Conclusion

The MPI Gene Glycosylation disorder type 1B Genetic Test is a valuable tool in diagnosing and managing MPI gene glycosylation disorder type 1B. By identifying mutations or variations in the MPI gene, this test provides crucial information for genetic counseling, family planning, and medical management decisions. With the help of NGS technology, DNA Labs UAE ensures accurate and reliable results for individuals with MPI gene glycosylation disorder type 1B.

Test Name MPI Gene Glycosylation disorder type 1B Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MPI Gene Glycosylation disorder type 1B NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 1B
Test Details

MPI Gene Glycosylation Disorder Type 1B NGS Genetic Test is a type of genetic test that is used to identify mutations or variations in the MPI gene. This gene is responsible for producing the enzyme mannose phosphate isomerase, which is involved in the production of glycosylation, a process that adds sugar molecules to proteins.

Mutations or variations in the MPI gene can lead to MPI gene glycosylation disorder type 1B, also known as MPI-CDG (Congenital Disorders of Glycosylation). This disorder affects the glycosylation process, leading to a range of symptoms including developmental delays, intellectual disability, growth abnormalities, liver dysfunction, and neurological problems.

The NGS (Next-Generation Sequencing) technique is used in this genetic test to analyze the DNA sequence of the MPI gene and identify any mutations or variations that may be present. This test can help in confirming a diagnosis of MPI gene glycosylation disorder type 1B and providing information about the specific genetic variant that is causing the disorder.

The results of the MPI Gene Glycosylation Disorder Type 1B NGS Genetic Test can be used for genetic counseling, family planning, and to guide medical management and treatment decisions for individuals with MPI gene glycosylation disorder type 1B.